Share Twitter LinkedIn Facebook Email Mohammad Jahanzeb, MD, FACP, explains the results of Keynote 189, PDL-1 expression and patient selection at Annual Meeting 2018. Advertisement
ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium Lung Cancer Treatment 4 Mins Read